Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Insight Molecular Diagnostics Inc. (IMDX)
A side-by-side comparison of Corbus Pharmaceuticals Holdings, Inc. and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.84HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
IMDX
Insight Molecular Diagnostics Inc.
$3.50HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — CRBP vs IMDX
growth of $100 · dividends reinvested · last 10yCRBP -97.2% (-30.1%/yr)IMDX -96.9% (-29.4%/yr)IMDX compounded faster over this window
CRBP IMDX
CRBP vs IMDX: by the numbers
- •IMDX is the larger company ($113M vs $108M market cap).
- •Both run net losses; CRBP's is the smaller (0.00% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | CRBP | IMDX |
|---|---|---|
| P/S ratio | N/A | 67.67 |
| P/B ratio | 1.06 | N/A |
Profitability
| Metric | CRBP | IMDX |
|---|---|---|
| Gross margin | 0.00% | 11.17% |
| Operating margin | 0.00% | -754.08% |
| Net margin | 0.00% | -2955.63% |
| ROE | -99.67% | N/A |
| ROIC | -101.30% | -223.06% |
Growth (annualized)
| Metric | CRBP | IMDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 27.24% |
| Total return CAGR (5Y) | -28.32% | -44.39% |
Frequently asked
- How have CRBP and IMDX total returns compared?
- Over the past 10 years, CRBP delivered -31.74% and IMDX delivered -29.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Corbus Pharmaceuticals ROEInsight Molecular Diagnostics ROECorbus Pharmaceuticals operating marginInsight Molecular Diagnostics operating marginCorbus Pharmaceuticals revenue growthInsight Molecular Diagnostics revenue growthCorbus Pharmaceuticals free cash flowInsight Molecular Diagnostics free cash flow
Corbus Pharmaceuticals & Insight Molecular Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.